Cargando…
Prostacyclin-producing human mesenchymal cells target H19 lncRNA to augment endogenous progenitor function in hindlimb ischaemia
Promoting the paracrine effects of human mesenchymal stem cell (hMSC) therapy may contribute to improvements in patient outcomes. Here we develop an innovative strategy to enhance the paracrine effects of hMSCs. In a mouse hindlimb ischaemia model, we examine the effects of hMSCs in which a novel tr...
Autores principales: | Deng, Yuxiao, Yang, Zhongwei, Terry, Toya, Pan, Su, Woodside, Darren G., Wang, Jingxiong, Ruan, Kehe, Willerson, James T., Dixon, Richard A. F., Liu, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835554/ https://www.ncbi.nlm.nih.gov/pubmed/27080438 http://dx.doi.org/10.1038/ncomms11276 |
Ejemplares similares
-
CD34(+)/M-cadherin(+) Bone Marrow Progenitor Cells Promote Arteriogenesis in Ischemic Hindlimbs of ApoE(−/−) Mice
por: Terry, Toya, et al.
Publicado: (2011) -
Influence of Androgen Receptor in Vascular Cells on Reperfusion following Hindlimb Ischaemia
por: Wu, Junxi, et al.
Publicado: (2016) -
Angiopoietin-2 impairs collateral artery growth associated with the suppression of the infiltration of macrophages in mouse hindlimb ischaemia
por: Tan, Xiaoyong, et al.
Publicado: (2016) -
Inhibition of myeloperoxidase increases revascularization and
improves blood flow in a diabetic mouse model of hindlimb
ischaemia
por: Weihrauch, Dorothee, et al.
Publicado: (2020) -
Enhanced Angiogenesis by 11βHSD1 Blockage Is Insufficient to Improve Reperfusion Following Hindlimb Ischaemia
por: Wu, Junxi, et al.
Publicado: (2022)